Contact us

Where your vision meets our dedication

We ensure that your journey from the lab to the patient is supported by a team that is as invested in your success as you are.

Learn more

Northway Biotech is a CDMO specializing in biologics and advanced therapies, supporting companies from early development through commercial manufacturing.

We are the partner you bring in early and keep for the long run.

Performance backed by numbers

0

Years of experience

0 +

Valuable Employees

0

Sites Across Europe and US

0 +

Satisfied Clients Globally

Our values

LEADERSHIP

At Northway, leadership is a daily practice where every team member is empowered to lead by example.

STRATEGIC DISCIPLINE

We guide our long-term vision through strategic thinking that connects global goals with local actions.

OPENNESS TO CHANGE

We turn every challenge into a new opportunity though
a culture of active listening and trust.    

CREATIVITY

We foster an environment where creative thinking and strategic innovation drive us forward.

EXCELLENT EXECUTION

We foster self-development at every level, driving our team toward excellent results.

OUR HISTORY

From Lab Startup to Global Biologics CDMO, our history is defined by a consistent drive for excellence and strategic growth.

FIRST cGMP FACILITY OPENS

FIRST cGMP FACILITY OPENS

A cGMP facility is constructed in Vilnius, featuring a 300 L working volume bioreactor for microbial fermentation and a 50 L wave bioreactor for mammalian production
EMA cGMP CERTIFICATION

EMA cGMP CERTIFICATION

The European Medicines Agency grants Vilnius site its first cGMP certificate and the first mammalian single-use bioreactor line (1,000 L) commences operations
BIOREACTOR CAPACITY DOUBLES

BIOREACTOR CAPACITY DOUBLES

A 2,000 L mammalian single-use bioreactor line is established in Vilnius
U.S. SITE BEGINS OPERATIONS

U.S. SITE BEGINS OPERATIONS

Waltham, MA facility launches its state-of-the-art process development labs
MICROBIAL & MAMMALIAN CAPACITY GROW

MICROBIAL & MAMMALIAN CAPACITY GROW

A large-scale microbial line (3,000-3,500 L working volume) is established through building expansion, and an additional 2 x 2,000 (total 4,000 L) mammalian line is added in Vilnius.
U.S. MANUFACTURING BEGINS

U.S. MANUFACTURING BEGINS

Northway inaugurates cGMP lines (2,000 L mammalian and 300 L working volume microbial) in Waltham, MA
NORTHWAY ENTERS GENE THERAPY

NORTHWAY ENTERS GENE THERAPY

Northway’s third facility dedicated to the manufacturing of gene therapy products begins operations in Vilnius
NORTHWAY OPENS NEW CELL THERAPY FACILITY

NORTHWAY OPENS NEW CELL THERAPY FACILITY

Building on the multi year expertise, Northway expands its capabilities with the new state-of-the-art site in Vilnius.
FOUNDED IN VILNIUS

FOUNDED IN VILNIUS

Northway Biotech is established and initiates operations as a process development laboratory in Vilnius, Lithuania

DID YOU KNOW...

…that Northway Biotech is building the largest biomanufacturing
hub in Europe?

Northway Biotech, with its project BIO CITY, aims to establish the largest biomanufacturing hub in Europe. This massive innovation district integrates world-class R&D and large-scale biomanufacturing capabilities across multiple modalities to redefine the future of life sciences on a global scale.

Learn more

DID YOU KNOW...

…why honeybees are the symbol of Northway Biotech?

The honeybee represents our belief that every individual contribution is vital to the success of the entire hive. It reflects our commitment to the collective effort required to achieve excellence for our clients.

Learn more

DID YOU KNOW...

…Lithuania is a global leader in scientific talent?

Lithuania boasts one of the highest concentrations of scientists and engineers in the European Union, with a particularly strong representation of women in STEM. This deep-rooted culture of education is the engine behind our precision and innovation at Northway Biotech.

Learn more

EXPLORE

Leadership

Meet the expert team driving our commitment to scientific excellence and global growth
Visit Page

Facilities

Explore our world-class laboratories and cGMP manufacturing sites in Europe and the US.
Visit Page

Career

Join us and contribute your skills to a team that values precision, growth, and collective success.
Visit Page

News

Don't miss the latest updates of our organization.
Visit Page

NORTHWAY BIOTECH & BIO CITY

Northway’s core biotechnology cluster is unified under the trademark Northway Biotech, which includes the key companies Northway Biotech Inc., Biotechpharma, Celltechna, and the Stem Cell Research Center (Kamieninių ląstelių tyrimų centras), operating 4 state-of-the-art biotechnology facilities across Europe and the US.

The group is also leading the development of the Bio City project, an established and rapidly expanding initiative set to become one of the largest biotechnology hubs in Europe.

NORTHWAY group of companies

Northway Healthcare Group comprises 17 companies operating across biotechnology, private medicine and investment clusters.

With a workforce of over 1,000 employees, Northway Healthcare Group brings together highly qualified scientists, biopharmaceutical experts, and medical professionals, supporting advanced research, development, and manufacturing activities across the organization.